Sign inJoin waitlistJoin the waitlist

John Day

Associate Program Director · Stanford Health Care

Credentials: · · · · ·

History

Stanford Health Care
Present
Center for Muscle Disorders · Stanford Health Care
Present
Clinical · Stanford Health Care
Present

University of California
1986–1987
Neurology
University of California-San Francisco
1983–1986
Pediatrics
Montefiore Medical Center/Albert Einstein College of Medicine
1980–1983
University of Minnesota
University of Minnesota Medical School
1973–1977
Oberlin College
1969–1973

Research

Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
New England Journal of Medicine · 2018 · 1,080 citations
Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9
Science · 2001 · 942 citations
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
The Lancet · 2016 · 775 citations

Richard Finkel
54 papers
BD
Basil Darras
44 papers
Jacqueline Montes
31 papers
Darryl De Vivo
30 papers
Jerry Mendell
30 papers
AP
Amy Pasternak
27 papers
AP
Alan Pestronk
19 papers
Jacinda Sampson
17 papers
Anne Connolly
16 papers
Diana Bharucha-Goebel
15 papers
EB
Elena Bravver
14 papers
Craig McDonald
12 papers

Grants

Myotonic Dystrophy: Molecular Pathophysiology and CNS Effects
National Institute of Neurological Disorders and Stroke · P01
Project lead · $2.6M · University of Florida
2008–2019
Muscular Dystrophy Center Core Laboratories
National Institute of Arthritis and Musculoskeletal and Skin Diseases · P30
Contact PI · $1.6M · University of Minnesota
2009–2014
Structural and Functional CNS Changes in Myotonic Dystrophy Types 1 and 2
National Institute of Neurological Disorders and Stroke · R01
Contact PI · $1.6M · Stanford University
2007–2013
GCRC-General Clinical Research Center
National Center for Research Resources · M01
Project lead · $88.1K · University of Minnesota
1997–2009

Clinical trials

Nemaline Myopathy Clinical Research Network (NM-CTRN)
Principal investigator · Not yet recruiting
Stanford University
2025–2029
Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
Principal investigator · Unknown
Stanford University
2022–2024
Children's Health Research Institute(CHRI), Stanford Lucile Packard Children Hospital (LPCH) Protocol on Myotonic Dystrophy
Principal investigator · Unknown
Stanford University
2013–2016
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
Site PI · Recruiting · Phase 1
Sarepta Therapeutics, Inc.
2020–2028